172 related articles for article (PubMed ID: 9581276)
1. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain.
Shin JE; Ackloo S; Mainkar AS; Monteiro MA; Pang H; Penner JL; Aspinall GO
Carbohydr Res; 1997 Dec; 305(2):223-32. PubMed ID: 9581276
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.
Aspinall GO; McDonald AG; Pang H; Kurjanczyk LA; Penner JL
Biochemistry; 1994 Jan; 33(1):241-9. PubMed ID: 8286348
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
Prendergast MM; Lastovica AJ; Moran AP
Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
Godschalk PC; Kuijf ML; Li J; St Michael F; Ang CW; Jacobs BC; Karwaski MF; Brochu D; Moterassed A; Endtz HP; van Belkum A; Gilbert M
Infect Immun; 2007 Mar; 75(3):1245-54. PubMed ID: 17261613
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.
Aspinall GO; McDonald AG; Pang H
Biochemistry; 1994 Jan; 33(1):250-5. PubMed ID: 7506928
[TBL] [Abstract][Full Text] [Related]
7. Serological diversity and chemical structures of Campylobacter jejuni low-molecular-weight lipopolysaccharides.
Aspinall GO; McDonald AG; Raju TS; Pang H; Mills SD; Kurjanczyk LA; Penner JL
J Bacteriol; 1992 Feb; 174(4):1324-32. PubMed ID: 1370951
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.
Endtz HP; Ang CW; van Den Braak N; Duim B; Rigter A; Price LJ; Woodward DL; Rodgers FG; Johnson WM; Wagenaar JA; Jacobs BC; Verbrugh HA; van Belkum A
J Clin Microbiol; 2000 Jun; 38(6):2297-301. PubMed ID: 10834992
[TBL] [Abstract][Full Text] [Related]
9. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.
Salloway S; Mermel LA; Seamans M; Aspinall GO; Nam Shin JE; Kurjanczyk LA; Penner JL
Infect Immun; 1996 Aug; 64(8):2945-9. PubMed ID: 8757818
[TBL] [Abstract][Full Text] [Related]
10. Chemical structure of the core oligosaccharide of aerotolerant Campylobacter jejuni O:2 lipopolysaccharide.
Hanniffy OM; Shashkov AS; Moran AP; Senchenkova SN; Savage AV
Carbohydr Res; 2001 Jan; 330(2):223-9. PubMed ID: 11217975
[TBL] [Abstract][Full Text] [Related]
11. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
12. Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide.
Aspinall GO; Lynch CM; Pang H; Shaver RT; Moran AP
Eur J Biochem; 1995 Aug; 231(3):570-8. PubMed ID: 7544281
[TBL] [Abstract][Full Text] [Related]
13. Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide.
Aspinall GO; McDonald AG; Raju TS; Pang H; Kurjanczyk LA; Penner JL; Moran AP
Eur J Biochem; 1993 May; 213(3):1029-37. PubMed ID: 8504799
[TBL] [Abstract][Full Text] [Related]
14. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.
Heikema AP; Jacobs BC; Horst-Kreft D; Huizinga R; Kuijf ML; Endtz HP; Samsom JN; van Wamel WJ
Clin Microbiol Infect; 2013 Feb; 19(2):E106-12. PubMed ID: 23173866
[TBL] [Abstract][Full Text] [Related]
15. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.
Ang CW; Laman JD; Willison HJ; Wagner ER; Endtz HP; De Klerk MA; Tio-Gillen AP; Van den Braak N; Jacobs BC; Van Doorn PA
Infect Immun; 2002 Mar; 70(3):1202-8. PubMed ID: 11854201
[TBL] [Abstract][Full Text] [Related]
16. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity.
Taboada EN; van Belkum A; Yuki N; Acedillo RR; Godschalk PC; Koga M; Endtz HP; Gilbert M; Nash JH
BMC Genomics; 2007 Oct; 8():359. PubMed ID: 17919333
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
[TBL] [Abstract][Full Text] [Related]
19. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
[TBL] [Abstract][Full Text] [Related]
20. Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides.
Aspinall GO; McDonald AG; Raju TS; Pang H; Moran AP; Penner JL
Eur J Biochem; 1993 May; 213(3):1017-27. PubMed ID: 8240486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
